Received Sep 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Y017512 | OT |
administering PROQUAD after experiencing a temperature excursion.; no adverse event; This spontaneous report was received from a health professional (other) and referred to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date, the patient received Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Y017512, expiration date: 19-Apr-2026) (dose, route was not reported) for prophylaxis, which was reconstituted with sterile diluent (lot# and expired date was not reported). The administered vaccine was experiencing a temperature excursion with -13.4 degree C for 9 Hours 32 Minutes (Product storage error). There was a previous temperature excursion with -12.9 degree C for 2 hours 22 minutes. No adverse event was reported. This is one of several reports from the same reporter.
sterile diluent